The European Medicines Agency (EMA) has given a positive opinion to a generic medicine, emtricitabine/tenofovir alafenamide, for the treatment of adults and adolescents infected with HIV type 1 (HIV-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results